Will online pharmacies blink off in India? EP News Bureau Apr 4, 2023 Tougher regulation, tighter rules, weeding out unscrupulous online pharmacies will ultimately serve the Indian patient better and…
Glenmark Pharma and SaNOtize announce results of its phase-III clinical trials on SaNOtize’s Nitric… EP News Bureau Jul 15, 2022 The trial administered to adult COVID-19 patients in India met the key endpoints and demonstrated reductions of viral load of 94…
Immune modulator drugs improves survival for people hospitalised with COVID-19 EP News Bureau Jun 3, 2022 NIH launched the ACTIV-1 immune modulators clinical trial to determine if certain drugs that help minimise the effects of an…
MSF provides free telemedicine consultation for COVID-19 patients in India EP News Bureau Jan 19, 2022 MSF doctors and nurses are available on the toll-free helpline 24 hours a day and seven days a week, and will conduct…
COVID-19 patients have higher risk of dying after cardiac arrest: Study Press Trust of India Feb 5, 2021 European Resuscitation Council and the Swedish Resuscitation Council issued guidelines recommending that bystanders who see a…
Humanigen, EVERSANA to partner for launch, commercialisation of Lenzilumab for COVID-19 treatment EP News Bureau Jan 10, 2021 Lenzilumab, a monoclonal antibody, is designed to prevent and treat cytokine storm, a complication considered to be a leading…
COVID-19 heart changes raise death risk; virus may be lead killer of young adults during surges Reuters Oct 27, 2020 The increased risk for death was statistically significant only when changes in the heart’s size, shape, structure, and function…
Biocon to launch drug for COVID-19 patients; priced at Rs 8,000 per vial Press Trust of India Jul 14, 2020 Itolizumab is the first novel biologic therapy to be approved anywhere in the world for treating patients with moderate to severe…
‘Indiscriminate use of remdesivir, tocilizumab on Covid patients can cause more harm than… Press Trust of India Jul 13, 2020 It said the pursuit of an effective treatment for COVID-19 has resulted in repurposing of several drugs which are not part of the…
Gilead says remdesivir reduced risk of death in Covid-19 patients, more studies needed Reuters Jul 11, 2020 The company, which had initially released the data from the trial in April, said the finding requires confirmation in clinical…